<html> <head> <title>Rule 20:51:25:02 Review of patient's record.</title> <META NAME="Keywords" Content="Administrative Rules 20:51:25:02"> <META NAME="Description" Content="Administrative Rules 20:51:25:02 Review of patient's record."> <meta name=Generator content="Microsoft Office HTML Filter 2.0"> <meta http-equiv=Content-Type content="text/html; charset=windows-1252"> <meta name=Originator content="Microsoft Word 10"> <style> <!-- --> </style> </head> <body lang=EN-US> <div> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b>20:51:25:02.&nbsp;&nbsp;Review of patient's record.</b> A pharmacist shall review the patient's record at the time a prescription drug order or prescription refill request is presented for dispensing for the purpose of identifying any of the following conditions:</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)&nbsp;&nbsp;Overutilization, use of a drug in quantities or for durations that put the patient at risk of an adverse medical result;</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)&nbsp;&nbsp;Underutilization, use of a drug by a patient in an insufficient quantity to achieve a desired therapeutic goal;</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)&nbsp;&nbsp;Therapeutic duplication, use of two or more drugs from the same therapeutic class in such a way that the combined daily dose puts the patient at risk of an adverse medical result;</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4)&nbsp;&nbsp;Drug-disease contraindications, the potential for or the occurrence of an undesirable alteration of the therapeutic effect of a given drug because of the presence of a disease condition in the patient or an adverse effect of the drug on the patient's disease condition;</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5)&nbsp;&nbsp;Adverse drug-drug interactions, the potential for or the occurrence of an adverse medical effect as a result of the patient using two or more drugs together;</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (6)&nbsp;&nbsp;Incorrect drug dosage, the dosage lies outside the daily dosage range specified in predetermined standards listed in 42 C.F.R. §&nbsp;456.703(f)(1), published in 57 Fed. Reg. 49,408 (November 2, 1992) as necessary to achieve therapeutic benefit. Dosage range is the strength multiplied by the quantity dispensed divided by days supply;</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7)&nbsp;&nbsp;Incorrect duration of drug treatment, the number of days of prescribed therapy exceeds or falls short of the recommendations contained in predetermined standards listed in 42 C.F.R. §&nbsp;456.703(f)(1), published in 57 Fed. Reg. 49,408 (November 2, 1992);</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8)&nbsp;&nbsp;Drug-allergy interactions, the significant potential for or the occurrence of an allergic reaction as a result of drug therapy; or</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (9)&nbsp;&nbsp;Clinical abuse or misuse.</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The pharmacist shall attempt to avoid or resolve any problems identified during the review and may, if necessary, consult with the practitioner.</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b>Source:</b> 19 SDR 93, effective December 31, 1992.</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b>General Authority:</b>SDCL <A HREF="/statutes/DisplayStatute.aspx?Type=Statute&Statute=36-11-68">36-11-68.</A></p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b>Law Implemented:</b>SDCL <A HREF="/statutes/DisplayStatute.aspx?Type=Statute&Statute=36-11-68">36-11-68.</A></p> </div> </body> </html>